Kevin Tang

Insider Reports History

Location
San Diego, CA
Signature
Kevin Tang
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin Tang:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aurinia Pharmaceuticals Inc. Director Common Shares 11,329,500 $132,328,560 $11.68 05 Aug 2025 By LP
Odonate Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Common Stock 12,767,435 $19,852,085 $1.55 19 Nov 2021 By LP
Jounce Therapeutics, Inc. Director, 10%+ Owner Common Stock 10,000 $18,500 $1.85 03 May 2023 By LP
Rain Oncology Inc. 10%+ Owner Common Stock 0 $0 $1.21 26 Jan 2024 By LP
Singular Genomics Systems, Inc. 10%+ Owner Common Stock 0 $0 $19.89 21 Feb 2025 By LP
TCR2 THERAPEUTICS INC. 10%+ Owner Common Stock 0 $0 $1.72 01 Jun 2023 By LP
Aptevo Therapeutics Inc. Exit Filing Common Stock 0 $0.9100 23 Nov 2021 By LP
LA JOLLA PHARMACEUTICAL CO Director, 10%+ Owner Common Stock 0 $6.23 22 Aug 2022 BY LP
LA JOLLA PHARMACEUTICAL CO Director, 10%+ Owner Series C-1(2) Convertible Preferred Stock 0 22 Aug 2022 BY LP
LA JOLLA PHARMACEUTICAL CO Director, 10%+ Owner Stock Option (Right to Buy) 0 22 Aug 2022 Direct

Insider Reports Filed by Kevin Tang

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AUPH Aurinia Pharmaceuticals Inc. 01 Aug 2025 3 +$13,590,000 4 Director 05 Aug 2025, 17:31
AUPH Aurinia Pharmaceuticals Inc. 28 Feb 2025 6 +$12,713,126 4 Director 04 Mar 2025, 17:03
/report/000141588925005952-tang-kevin-2025-02-21 Singular Genomics Systems, Inc. 21 Feb 2025 1 $0 4 10%+ Owner 27 Feb 2025, 20:54
AUPH Aurinia Pharmaceuticals Inc. 05 Dec 2024 3 +$10,822,000 4 Director 09 Dec 2024, 16:52
/report/000141588924023623-tang-kevin-2024-09-16 Singular Genomics Systems, Inc. 16 Sep 2024 3 +$1,806,220 4 10%+ Owner 18 Sep 2024, 16:31
/report/000141588924023620-tang-kevin-2024-09-16 Singular Genomics Systems, Inc. 16 Sep 2024 0 $0 3 10%+ Owner 18 Sep 2024, 16:27
AUPH Aurinia Pharmaceuticals Inc. 12 Sep 2024 0 $0 3 Director 23 Sep 2024, 16:05
/report/000141588924002278-tang-kevin-c-2024-01-26 Rain Oncology Inc. 26 Jan 2024 1 $0 4 10%+ Owner 02 Feb 2024, 16:00
/report/000141588923016655-tang-kevin-c-2023-12-14 Rain Oncology Inc. 14 Dec 2023 3 -$209,413 4 10%+ Owner 18 Dec 2023, 18:29
/report/000120919123052788-tang-kevin-c-2023-10-11 Rain Oncology Inc. 11 Oct 2023 5 +$279,030 4 10%+ Owner 13 Oct 2023, 16:57
/report/000141588924003784-tang-kevin-c-2023-06-01 TCR2 THERAPEUTICS INC. 01 Jun 2023 1 $0 4 10%+ Owner 14 Feb 2024, 17:25
/report/000120919123033446-tang-kevin-c-2023-05-30 Rain Oncology Inc. 30 May 2023 9 +$1,158,764 4 10%+ Owner 01 Jun 2023, 18:46
/report/000120919123033445-tang-kevin-c-2023-05-30 Rain Oncology Inc. 30 May 2023 0 $0 3 10%+ Owner 01 Jun 2023, 18:44
/report/000120919123033041-tang-kevin-c-2023-05-25 TCR2 THERAPEUTICS INC. 25 May 2023 1 +$86,000 4 10%+ Owner 30 May 2023, 20:02
/report/000120919123029527-tang-kevin-c-2023-05-11 TCR2 THERAPEUTICS INC. 11 May 2023 2 +$87,649 4 10%+ Owner 15 May 2023, 17:12
/report/000120919123028565-tang-kevin-c-2023-05-08 TCR2 THERAPEUTICS INC. 08 May 2023 3 +$163,777 4 10%+ Owner 10 May 2023, 19:02
/report/000120919123027833-tang-kevin-c-2023-05-03 TCR2 THERAPEUTICS INC. 03 May 2023 4 +$547,944 4 10%+ Owner 05 May 2023, 18:52
/report/000120919123027832-tang-kevin-c-2023-05-03 TCR2 THERAPEUTICS INC. 03 May 2023 0 $0 3 10%+ Owner 05 May 2023, 18:49
/report/000120919123027688-tang-kevin-c-2023-05-03 Jounce Therapeutics, Inc. 03 May 2023 2 +$87,571,839 4 Director, 10%+ Owner 05 May 2023, 16:37
/report/000120919123018721-tang-kevin-c-2023-03-13 Jounce Therapeutics, Inc. 13 Mar 2023 2 +$85,958 4 10%+ Owner 14 Mar 2023, 20:39
/report/000120919123018717-tang-kevin-c-2023-03-13 Jounce Therapeutics, Inc. 13 Mar 2023 0 $0 3 10%+ Owner 14 Mar 2023, 20:38
/report/000089924322029660-tang-kevin-c-2022-08-22 LA JOLLA PHARMACEUTICAL CO 22 Aug 2022 11 -$59,857,429 4 Director, 10%+ Owner 24 Aug 2022, 20:21
/report/000120919122047314-tang-kevin-c-2022-08-22 LA JOLLA PHARMACEUTICAL CO 22 Aug 2022 2 -$59,857,429 4 Director, 10%+ Owner 24 Aug 2022, 16:02
/report/000120919122003317-tang-kevin-c-2022-01-12 LA JOLLA PHARMACEUTICAL CO 12 Jan 2022 1 $0 4 Director, 10%+ Owner 14 Jan 2022, 15:05
/report/000120919121067347-tang-kevin-c-2021-11-29 LA JOLLA PHARMACEUTICAL CO 29 Nov 2021 5 -$1,734,150 4 Director, 10%+ Owner 01 Dec 2021, 18:07
APVO Aptevo Therapeutics Inc. 23 Nov 2021 7 -$10,368,236 4 Exit Filing 26 Nov 2021, 12:02
APVO Aptevo Therapeutics Inc. 18 Nov 2021 10 -$6,500,411 4 10%+ Owner 22 Nov 2021, 16:26
/report/000120919121065826-tang-kevin-c-2021-11-17 Odonate Therapeutics, Inc. 17 Nov 2021 8 -$5,730,557 4 Chief Executive Officer, Director, 10%+ Owner 19 Nov 2021, 15:38
/report/000120919121036939-tang-kevin-c-2021-05-27 LA JOLLA PHARMACEUTICAL CO 27 May 2021 4 +$1,095,693 4 Director, 10%+ Owner 01 Jun 2021, 18:42
/report/000120919121035962-tang-kevin-c-2021-05-24 LA JOLLA PHARMACEUTICAL CO 24 May 2021 4 +$1,577,731 4 Director, 10%+ Owner 26 May 2021, 16:56